Amgen reports better than expected Q2 numbers, raises guidance
Amgen (AMGN) reported its second quarter earnings, generally besting the market estimates. The company’s earnings per share stood at $4.25, up 7.05 percent on a year-over-year basis. It also surpassed the market expectation of $3.84 in earnings per share.
Amgen reported that despite the onslaught of the coronavirus pandemic, its revenue grew 6 percent on a year-over-year basis to $6.2 billion for the second quarter of the year. However, its GAAP earnings per share declined 15 percent to $3.05, owing to amortization costs associated